# Elevent Index Academy: framework reference Source: Elevent Index: From Pitch Deck to Investment Decisions, by Dr. Bitan Ghosh. Official framework website: https://www.eleventindex.com/ Academy HTML reference: https://academy.eleventindex.com/learn/#framework-reference This is a curated educational reference already available on the Academy website, not a copy of the complete book. ## What is Elevent Index? Elevent Index separates Investment Quality, the substance of a startup's business, from Funding Readiness, its preparation for the fundraising process. The Academy teaches illustrative dimension-level scoring, not the full certified assessment. ## Investment Quality Score (IQS) IQS uses 11 dimensions. Each dimension normally averages ten evidence-rated sub-parameters. IQS is scored on a 0–10 scale with stage-specific dimension weights. 1. Founder and Leadership Strength: Can this team execute, learn, and hold together under pressure? 2. Market Opportunity Assessment: Is the market large, reachable, and genuinely changing? 3. Product and Innovation Strength: Does the product solve a real problem in a defensible way? 4. Business Model Viability: Does each unit of revenue eventually pay for itself? 5. Financial Strength: Do the numbers show discipline, runway, and honest forecasting? 6. Competitive Positioning: Why does this company win against the alternatives? 7. Customer and Growth Indicators: Is there evidence that customers pay, stay, and refer? 8. Governance and Compliance: Are ownership, controls, and regulation under control? 9. Operational Readiness: Can operations absorb the growth the plan assumes? 10. Investment and Exit Potential: Is there a credible route to a return for this investor? 11. Future Sustainability Index: Will the business still be healthy after the next round? ## Funding Readiness Score (FRS) FRS uses five dimensions. Each dimension normally averages ten evidence-rated sub-parameters. FRS is scored on a 0–10 scale with stage-specific dimension weights. 1. Financial Readiness: Are books, models, and metrics investor-grade? 2. Legal and Governance Readiness: Is the cap table clean and the paperwork in order? 3. Fundraising Strategy Readiness: Is there a target list, a narrative, and a raise sized to the plan? 4. Due Diligence Readiness: Could a data room survive an investor audit tomorrow? 5. Transaction Readiness: Can the team negotiate terms and close without chaos? ## Capital Readiness Score (CRS) CRS = (7 × IQS) + (3 × FRS). IQS and FRS have 0–10 ranges; CRS has a 0–100 range. Investment Quality contributes 70% and Funding Readiness 30%. In the live workshop, unscored dimensions are excluded from the provisional subtotal. They are not silently assigned a middle score. All 16 dimensions must be entered before interpreting the matrix and priority gaps. ## Startup maturity stages and dimension weights ### 1. Idea / Pre-Seed Evidence is thin. Judge the founder and the problem, not revenue. IQS weights: Founder and Leadership Strength 20%; Market Opportunity Assessment 15%; Product and Innovation Strength 15%; Business Model Viability 10%; Financial Strength 3%; Competitive Positioning 8%; Customer and Growth Indicators 3%; Governance and Compliance 5%; Operational Readiness 5%; Investment and Exit Potential 6%; Future Sustainability Index 10%. FRS weights: Financial Readiness 10%; Legal and Governance Readiness 20%; Fundraising Strategy Readiness 50%; Due Diligence Readiness 5%; Transaction Readiness 15%. ### 2. MVP / Pilot Early product signals matter more than financial polish. IQS weights: Founder and Leadership Strength 18%; Market Opportunity Assessment 13%; Product and Innovation Strength 14%; Business Model Viability 10%; Financial Strength 5%; Competitive Positioning 8%; Customer and Growth Indicators 10%; Governance and Compliance 4%; Operational Readiness 6%; Investment and Exit Potential 4%; Future Sustainability Index 8%. FRS weights: Financial Readiness 20%; Legal and Governance Readiness 20%; Fundraising Strategy Readiness 40%; Due Diligence Readiness 10%; Transaction Readiness 10%. ### 3. Early Revenue First paying customers. Revenue quality and repeatable delivery matter. IQS weights: Founder and Leadership Strength 15%; Market Opportunity Assessment 10%; Product and Innovation Strength 10%; Business Model Viability 12%; Financial Strength 10%; Competitive Positioning 8%; Customer and Growth Indicators 12%; Governance and Compliance 6%; Operational Readiness 6%; Investment and Exit Potential 5%; Future Sustainability Index 6%. FRS weights: Financial Readiness 25%; Legal and Governance Readiness 25%; Fundraising Strategy Readiness 25%; Due Diligence Readiness 15%; Transaction Readiness 10%. ### 4. Growth Unit economics, governance and repeatability gain weight. IQS weights: Founder and Leadership Strength 12%; Market Opportunity Assessment 10%; Product and Innovation Strength 8%; Business Model Viability 12%; Financial Strength 12%; Competitive Positioning 10%; Customer and Growth Indicators 12%; Governance and Compliance 8%; Operational Readiness 8%; Investment and Exit Potential 4%; Future Sustainability Index 4%. FRS weights: Financial Readiness 30%; Legal and Governance Readiness 25%; Fundraising Strategy Readiness 20%; Due Diligence Readiness 15%; Transaction Readiness 10%. ### 5. Scale-Up / Pre-IPO Mature expectations. Weak controls cannot hide behind momentum. IQS weights: Founder and Leadership Strength 10%; Market Opportunity Assessment 8%; Product and Innovation Strength 6%; Business Model Viability 10%; Financial Strength 15%; Competitive Positioning 10%; Customer and Growth Indicators 10%; Governance and Compliance 12%; Operational Readiness 10%; Investment and Exit Potential 5%; Future Sustainability Index 4%. FRS weights: Financial Readiness 30%; Legal and Governance Readiness 30%; Fundraising Strategy Readiness 15%; Due Diligence Readiness 15%; Transaction Readiness 10%. ## Capital Readiness Matrix The matrix has five IQS bands and five FRS bands: Very Low, Low, Moderate, High, Very High. - IQS Very Low / FRS Very Low: Not Investable - IQS Very Low / FRS Low: Not Investable - IQS Very Low / FRS Moderate: Not Investable - IQS Very Low / FRS High: Not Investable - IQS Very Low / FRS Very High: Not Investable - IQS Low / FRS Very Low: Very Weak, Not Investable - IQS Low / FRS Low: High Risk, Not Investable - IQS Low / FRS Moderate: Weak, Needs Major Work - IQS Low / FRS High: High Risk, Proceed Carefully - IQS Low / FRS Very High: Possible, Needs Validation - IQS Moderate / FRS Very Low: Low Potential, Not Investable - IQS Moderate / FRS Low: Uncertain, Early Work Needed - IQS Moderate / FRS Moderate: Moderate, Needs Strengthening - IQS Moderate / FRS High: Investable with Conditions - IQS Moderate / FRS Very High: Good Candidate, Investable - IQS High / FRS Very Low: Good Potential, Not Ready - IQS High / FRS Low: Potential, Needs Work - IQS High / FRS Moderate: Good, Prepare Further - IQS High / FRS High: Investable, High Confidence - IQS High / FRS Very High: Very Strong, Highly Investable - IQS Very High / FRS Very Low: High Potential, Not Ready - IQS Very High / FRS Low: High Potential, Not Ready - IQS Very High / FRS Moderate: Promising, Needs Preparation - IQS Very High / FRS High: Strong Candidate, Investable - IQS Very High / FRS Very High: Excellent, Highly Investable Read both axes and the underlying evidence, not just the combined score. ## Frequently asked questions ### What is Elevent Index? Elevent Index is a startup assessment framework by Dr. Bitan Ghosh, presented in the book Elevent Index: From Pitch Deck to Investment Decisions. It separates Investment Quality, the substance of a business, from Funding Readiness, its preparation for the fundraising process. These two assessments produce the Investment Quality Score (IQS) and Funding Readiness Score (FRS), which combine into the Capital Readiness Score (CRS). The Capital Readiness Matrix keeps both scores visible so that business strengths are not confused with fundraising preparation. Elevent Index Academy provides an introductory learning and scoring experience, not the full certified assessment. ### What is Investment Quality Score (IQS)? Investment Quality Score (IQS) assesses whether a startup has business substance that deserves capital. It covers 11 dimensions, including founder and leadership strength, market opportunity, product and innovation, business model viability, financial strength, customer and growth indicators, and governance. Each dimension normally averages ten evidence-rated sub-parameters on a 0–10 scale. Stage-specific dimension weights produce an overall IQS on a 0–10 scale. IQS contributes 70% of the combined Capital Readiness Score, but should also be read separately from Funding Readiness Score: strong pitch preparation cannot compensate for weak business evidence. The Academy workshop accepts dimension averages directly for illustrative practice. ### What is Funding Readiness Score (FRS)? Funding Readiness Score (FRS) assesses how prepared a startup is to run and complete a fundraising process. Its five dimensions are Financial Readiness, Legal and Governance Readiness, Fundraising Strategy Readiness, Due Diligence Readiness, and Transaction Readiness. Each dimension normally averages ten evidence-rated sub-parameters; stage-specific weights combine the dimension scores into an FRS on a 0–10 scale. FRS contributes 30% of the Capital Readiness Score. It answers a different question from Investment Quality Score: a business can have strong potential but incomplete documentation, or polished fundraising materials without strong business substance. Read both axes in the Capital Readiness Matrix before deciding what needs improvement. ### How is Capital Readiness Score (CRS) calculated? Capital Readiness Score (CRS) is calculated as CRS = (7 × IQS) + (3 × FRS). Investment Quality Score (IQS) and Funding Readiness Score (FRS) each use a 0–10 scale, so CRS uses a 0–100 scale. The formula gives business quality 70% of the combined score and fundraising preparation 30%; maturity-stage weights apply within IQS and FRS before they are combined. In the Academy live workshop, enter all 11 IQS and five FRS dimension scores for a complete result. An incomplete subtotal is provisional, not a finished assessment. Interpret the resulting CRS alongside both axes of the 5 × 5 Capital Readiness Matrix, not as a funding guarantee. ### Does the Index replace investor judgement? No. Elevent Index structures investor judgement rather than replacing it. Investment Quality Score (IQS), Funding Readiness Score (FRS), and the Capital Readiness Matrix help identify where a startup appears strong, where evidence is incomplete, and what deserves further investigation. Investors still need to verify the underlying evidence and perform financial, legal, commercial and other relevant due diligence. A numerical score cannot establish that a claim is true or that an investment fits an investor’s objectives. Use the framework to organise questions and focus review, not to approve or reject a startup mechanically. The Academy’s introductory exercises are not a substitute for professional assessment. ### Should founders score themselves or get outside review? Both are useful for different reasons. Founder self-assessment with Elevent Index builds awareness of business-quality gaps and fundraising-preparation gaps before approaching investors. An outside review tests whether the evidence supports the scores and helps challenge optimistic assumptions. For a meaningful comparison, reviewers should use the same maturity stage and explain the evidence behind each dimension rating. If scores differ, investigate the reason instead of simply averaging away the disagreement. The Academy workshop can support this discussion by keeping Investment Quality Score (IQS) and Funding Readiness Score (FRS) separate. Self-entered workshop results remain illustrative and should not be presented as a certified Elevent Index assessment. ### Is one low dimension an automatic rejection? No. A low Elevent Index dimension score is a signal to investigate, not an automatic investment decision. Read the weakness alongside the other Investment Quality or Funding Readiness dimensions, the startup’s maturity stage, and the evidence supporting the rating. Stage-specific weights change how much that weakness contributes to IQS, FRS and the combined Capital Readiness Score. A low score may reflect missing evidence, an early-stage limitation or a substantive business risk; those possibilities need different responses. Serious weaknesses still deserve attention even when the overall CRS is high. Use the Capital Readiness Matrix and due diligence to understand the issue rather than treating a single number as a universal rejection rule. ### Does a high CRS guarantee funding? No. A high Capital Readiness Score (CRS) indicates assessed readiness under the Elevent Index framework, not a guaranteed fundraising outcome. CRS combines Investment Quality Score (IQS) and Funding Readiness Score (FRS), but the result depends on the underlying evidence, dimension ratings and maturity-stage assumptions. An investor must still verify the business and decide whether it fits their investment objectives and risk appetite. Read the Capital Readiness Matrix as well as the combined score, because a single total can conceal different quality and preparation gaps. Academy workshop scores are illustrative learning inputs, not a promise of funding or a replacement for due diligence. ### When should a startup be reassessed? Reassess a startup with Elevent Index at meaningful milestones when its evidence has genuinely changed. Relevant changes may include new product validation, paying-customer evidence, a different revenue pattern, improved financial reporting, completed legal documentation or movement into another maturity stage. Update the affected dimension ratings and check whether the selected stage and its weights still fit before recalculating Investment Quality Score (IQS), Funding Readiness Score (FRS), and Capital Readiness Score (CRS). Keep a record of the stage, evidence and assumptions used so that changes in results can be explained. Do not treat an old score as a permanent label or repeatedly rescore unchanged evidence just to obtain a higher number. ### What if the stage is unclear? Use judgement to select the maturity stage that best matches the startup’s current evidence, not its ambitions for the next funding round. Elevent Index uses five stages: Idea / Pre-Seed, MVP / Pilot, Early Revenue, Growth, and Scale-Up / Pre-IPO. If the evidence falls between neighbouring stages, start with the more conservative stage and run a sensitivity check using the neighbouring stage. Compare how the stage-specific weights affect Investment Quality Score (IQS), Funding Readiness Score (FRS), and Capital Readiness Score (CRS). Explain why the stage is uncertain and what evidence would resolve that uncertainty. Choosing a stage only because it produces a more attractive score would weaken the assessment. ### Is the score the end of the process? No. The Elevent Index score is a starting point for interpretation and action. After calculating Investment Quality Score (IQS), Funding Readiness Score (FRS), and Capital Readiness Score (CRS), read the 5 × 5 Capital Readiness Matrix to understand how business substance and fundraising preparation interact. Examine the dimension-level evidence, identify the most important gaps, and decide what to validate or improve next. The Academy workshop highlights weighted CRS drag to support that discussion, but a numerical priority does not replace judgement about serious risks. Take action, gather better evidence and reassess at meaningful milestones. A final investment decision still requires human judgement and appropriate due diligence. ## Limits and privacy No score guarantees investment, replaces investor judgment or replaces due diligence. Numerical exercises are illustrative, not company case studies. The AI companion can be wrong and is not a live conversation with the author. Progress and workshop scores are stored in the visitor's browser. Chat questions and recent conversation history are sent for AI processing; see https://academy.eleventindex.com/privacy/. Contact: contact@bitanghosh.com.